BrainStorm gets FDA okay for stem cell trial in MS patients
TEL AVIV (Reuters) – BrainStorm Cell Therapeutics Inc has received approval from the U.S. Food and Drug Administration to begin a clinical trial of its experimental stem cell treatment in…
by October Gallery
TEL AVIV (Reuters) – BrainStorm Cell Therapeutics Inc has received approval from the U.S. Food and Drug Administration to begin a clinical trial of its experimental stem cell treatment in…